Cell therapy options for patients with dystrophic dermatologic epidermolysis bullosa (RDEB)
September, 11 2024
A study published in the Journal of Dermatological Treatment details the use of mesenchymal stromal cells (MSC) to treat RDEB, a severe genetic disorder in which the skin becomes extremely fragile and prone to forming painful ulcers and chronic wounds. This disease not only impairs quality of life, but is also associated with a risk of developing skin cancer.
A study published in the Journal of Dermatological Treatment details the use of mesenchymal stromal cells (MSC) to treat RDEB, a severe genetic disorder in which the skin becomes extremely fragile and prone to forming painful ulcers and chronic wounds. This disease not only impairs quality of life, but is also associated with a risk of developing skin cancer.
Latest news
Stem cells: restoring the liver according to science
January, 16 2025
Exosoms: helping blood vessels after treatment
January, 01 2025
Exosomes on the lookout for lung disease
November, 19 2024
Stem cells and exosomes against DIC syndrome
November, 16 2024
How do stem cells help fight kidney aging?
September, 21 2024